Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosusJing He, Zhanguo Li, Yuebo Jin et al.|Nature Medicine|2016Cited by 570
Oscillatory Dynamics in the Frontoparietal Attention Network during Sustained Attention in the FerretKristin K. Sellers, Flavio Frӧhlich, Chunxiu Yu et al.|Cell Reports|2016Cited by 54
Halofuginone protects against advanced glycation end products‑induced injury of H9C2 cells via alleviating endoplasmic reticulum stress‑associated apoptosis and inducing autophagyYuhui Li, Qin Hu|Molecular Medicine Reports|2019Cited by 9